Furthermore, the loss of LKB1 in lung adenocarcinoma cells activated TEAD, which directly transcribed ZEB2 and repressed DNp63 to regulate cell fate and lineage conversion in lung cancer progression [130]. The gene discussed is ZEB2; the disease is lung cancer.